Nuno Tavares

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 6

Top Topics

Affordable Care Act

Patients Undergoing

Top Venues

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Antonio Araujo, Nuno Tavares, Ana Luísa Faria, Rosa Gomes, Joana Carvalho Mendonça, Bárbara Parente, Andreia Capela, Fernando Barata, Ana Macedo
Evaluation of Current Antiemetic Therapy Response in Patients Undergoing MEC or HEC Regimens in Portugal. Current oncology (Toronto, Ont.) 30 (2) (2023)
Antonio Araujo, Nuno Tavares, Ana Luísa Faria, Rosa Gomes, Joana Carvalho Mendonça, Bárbara Parente, Andreia Capela, Fernando Barata, Ana Macedo
Evaluation of Current Antiemetic Therapy Response in Patients Undergoing MEC or HEC Regimens in Portugal. Current oncology (Toronto, Ont.) 30 (2) (2023)
Antonio Araujo, Nuno Tavares, Ana Luísa Faria, Rosa Gomes, Joana Carvalho Mendonça, Bárbara Parente, Andreia Capela, Fernando Barata, Ana Macedo
Evaluation of Current Antiemetic Therapy Response in Patients Undergoing MEC or HEC Regimens in Portugal. Current oncology (Toronto, Ont.) 30 (2) (2023)
Antonio Araujo, Nuno Tavares, Ana Luísa Faria, Rosa Gomes, Joana Carvalho Mendonça, Bárbara Parente, Andreia Capela, Fernando Barata, Ana Macedo
Evaluation of Current Antiemetic Therapy Response in Patients Undergoing MEC or HEC Regimens in Portugal. Current oncology (Toronto, Ont.) 30 (2) (2023)
Antonio Araujo, Nuno Tavares, Ana Luísa Faria, Rosa Gomes, Joana Carvalho Mendonça, Bárbara Parente, Andreia Capela, Fernando Barata, Ana Macedo
Evaluation of Current Antiemetic Therapy Response in Patients Undergoing MEC or HEC Regimens in Portugal. Current oncology (Toronto, Ont.) 30 (2) (2023)
Antonio Araujo, Nuno Tavares, Ana Luísa Faria, Rosa Gomes, Joana Carvalho Mendonça, Bárbara Parente, Andreia Capela, Fernando Barata, Ana Macedo
Evaluation of Current Antiemetic Therapy Response in Patients Undergoing MEC or HEC Regimens in Portugal. Current oncology (Toronto, Ont.) 30 (2) (2023)